Literature DB >> 25854904

Diagnostic and prognostic value of sCD14-ST--presepsin for patients admitted to hospital intensive care unit (ICU).

Matej Godnic1, David Stubljar, David Stubjar, Miha Skvarc, Tomislav Jukic.   

Abstract

BACKGROUND: Sepsis is a serious problem in intensive care units all over the world. Biomarkers could be useful to identify patients at risk. We focused especially on the performance of presepsin (sCD14-ST), compared to C-reactive protein (CRP), procalcitonin (PCT) and CD64, to determine its diagnostic and prognostic indications.
METHODS: The study was conducted on 47 hospitalized patients after procedures, who were divided into three groups; systemic inflammatory response (SIRS), sepsis and septic shock. Expression of CD64 on neutrophils presented as CD64 index, sCD14-ST, CRP and PCT were measured in whole blood or plasma samples. All patients had standard samples like urine, respiratory tract samples etc. taken for culturing. Blood cultures were drawn to confirm bloodstream infection.
RESULTS: Forty (85 %) patients had SIRS with bacterial infection and seven (15 %) patients had SIRS with no infection. All infections were confirmed with blood cultures. Biomarkers were evaluated in all patients. In patients with confirmed infection the values were high. The patients with bacterial infection showed statistical significance with CD64 index (p = 0.003), CRP (p = 0.049) and sCD14-ST (p = 0.026), but not with PCT (p = 1.000). The severity of diagnosed SIRS was significant only with PCT (p < 0.001).
CONCLUSION: CD64 index, CRP and sCD14-ST served as good parameters to determine possible infection in patients that needed intensive care after major procedures. Values of PCT were the only ones to predict SIRS severity and could distinguish between sepsis and severe sepsis or septic shock.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25854904     DOI: 10.1007/s00508-015-0719-5

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  38 in total

1.  Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria.

Authors:  C B Chiwakata; C Manegold; L Bönicke; I Waase; C Jülch; M Dietrich
Journal:  J Infect Dis       Date:  2001-03-01       Impact factor: 5.226

2.  Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis.

Authors:  Yasunori Yaegashi; Kamon Shirakawa; Nobuhiro Sato; Yasushi Suzuki; Masahiro Kojika; Satoko Imai; Gaku Takahashi; Michiko Miyata; Shoji Furusako; Shigeatsu Endo
Journal:  J Infect Chemother       Date:  2005-10       Impact factor: 2.211

3.  Procalcitonin as a prognostic biomarker of severe sepsis and septic shock.

Authors:  José Raimundo Araujo de Azevedo; Orlando Jorge Martins Torres; Nicolau Gregori Czeczko; Felipe Francisco Tuon; Paulo Afonso Nunes Nassif; Gleim Dias de Souza
Journal:  Rev Col Bras Cir       Date:  2012-12

4.  Usefulness of presepsin (sCD14-ST) measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.

Authors:  Tatsuyori Shozushima; Gaku Takahashi; Naoya Matsumoto; Masahiro Kojika; Yoshikazu Okamura; Shigeatsu Endo
Journal:  J Infect Chemother       Date:  2011-05-12       Impact factor: 2.211

5.  Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study.

Authors:  Valeria Sargentini; Giancarlo Ceccarelli; Mariadomenica D'Alessandro; Daniela Collepardo; Andrea Morelli; Annalia D'Egidio; Sabrina Mariotti; Anna Maria Nicoletti; Berta Evangelista; Gabriella D'Ettorre; Antonio Angeloni; Mario Venditti; Alessandra Bachetoni
Journal:  Clin Chem Lab Med       Date:  2015-03       Impact factor: 3.694

6.  Procalcitonin in hantavirus infections.

Authors:  Matjaž Jereb; Nina K Lunaček; Tadeja Kotar; Ana Saksida; Miroslav Petrovec; Tatjana Avšič-Županc
Journal:  Scand J Clin Lab Invest       Date:  2011-02-23       Impact factor: 1.713

7.  In critically ill patients the procalcitonin level can be misleading.

Authors:  Jacqueline Koeze; M G Ron Hendrix; Frank A J T M van den Bergh; René M L Brouwer; Jan G Zijlstra
Journal:  Crit Care       Date:  2011-04-28       Impact factor: 9.097

Review 8.  Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 2: C-reactive protein in the diagnosis of bacteraemia.

Authors:  Amy Au-Yong
Journal:  Emerg Med J       Date:  2012-05       Impact factor: 2.740

9.  Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.

Authors:  Shigeatsu Endo; Yasushi Suzuki; Gaku Takahashi; Tatsuyori Shozushima; Hiroyasu Ishikura; Akira Murai; Takeshi Nishida; Yuhei Irie; Masanao Miura; Hironobu Iguchi; Yasuo Fukui; Kimiaki Tanaka; Tsuyoshi Nojima; Yoshikazu Okamura
Journal:  J Infect Chemother       Date:  2012-06-13       Impact factor: 2.211

10.  Comparative assessment of cytokines and other inflammatory markers for the early diagnosis of neonatal sepsis-a case control study.

Authors:  Akila Prashant; Prashant Vishwanath; Praveen Kulkarni; Prashanth Sathya Narayana; Vijaykumar Gowdara; Suma M Nataraj; Rashmi Nagaraj
Journal:  PLoS One       Date:  2013-07-15       Impact factor: 3.240

View more
  7 in total

1.  Diagnostic and Prognostic Value of Presepsin for Subclinical Chorioamnionitis in Pregnancies between 23-28 Week with Preterm Premature Rupture of the Membranes.

Authors:  Erbil Çakar; Şule Eren Çakar; Habibe Ayvacı Taşan; Deniz Karçaaltıncaba; Mehmet Baki Şentürk; Nermin Koç; Ramazan Uluhan
Journal:  Balkan Med J       Date:  2016-11-01       Impact factor: 2.021

2.  The accuracy of presepsin for the diagnosis of sepsis from SIRS: a systematic review and meta-analysis.

Authors:  Zhongjun Zheng; Libing Jiang; Ligang Ye; Yuzhi Gao; Luping Tang; Mao Zhang
Journal:  Ann Intensive Care       Date:  2015-12-08       Impact factor: 6.925

3.  Biomarkers for diagnosis of sepsis in patients with systemic inflammatory response syndrome: a systematic review and meta-analysis.

Authors:  Yong Liu; Jun-Huan Hou; Qing Li; Kui-Jun Chen; Shu-Nan Wang; Jian-Min Wang
Journal:  Springerplus       Date:  2016-12-12

4.  Comparison of diagnostic accuracy in sepsis between presepsin, procalcitonin, and C-reactive protein: a systematic review and meta-analysis.

Authors:  Chin-Chieh Wu; Hao-Min Lan; Shih-Tsung Han; Chung-Hsien Chaou; Chun-Fu Yeh; Su-Hsun Liu; Chih-Huang Li; Gerald N Blaney; Zhen-Ying Liu; Kuan-Fu Chen
Journal:  Ann Intensive Care       Date:  2017-09-06       Impact factor: 6.925

5.  Diagnostic value of procalcitonin and presepsin for sepsis in critically ill adult patients: a systematic review and meta-analysis.

Authors:  Yutaka Kondo; Yutaka Umemura; Kei Hayashida; Yoshitaka Hara; Morio Aihara; Kazuma Yamakawa
Journal:  J Intensive Care       Date:  2019-04-15

6.  Evaluation of sTREM1 and suPAR Biomarkers as Diagnostic and Prognostic Predictors in Sepsis Patients.

Authors:  Asmaa Nasr El-Din; Abdelhady Ragab Abdel-Gawad; Wesam Abdelgalil; Nahed F Fahmy
Journal:  Infect Drug Resist       Date:  2021-08-31       Impact factor: 4.003

7.  Usefulness of sialic acid for diagnosis of sepsis in critically ill patients: a retrospective study.

Authors:  Bo Yao; Wen-Juan Liu; Di Liu; Jin-Yan Xing; Li-Juan Zhang
Journal:  BMC Anesthesiol       Date:  2020-11-03       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.